
<ns0:uwmetadata xmlns:ns0="http://phaidra.univie.ac.at/XML/metadata/V1.0" xmlns:ns1="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0" xmlns:ns10="http://phaidra.univie.ac.at/XML/metadata/provenience/V1.0" xmlns:ns11="http://phaidra.univie.ac.at/XML/metadata/provenience/V1.0/entity" xmlns:ns12="http://phaidra.univie.ac.at/XML/metadata/digitalbook/V1.0" xmlns:ns13="http://phaidra.univie.ac.at/XML/metadata/etheses/V1.0" xmlns:ns2="http://phaidra.univie.ac.at/XML/metadata/extended/V1.0" xmlns:ns3="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/entity" xmlns:ns4="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/requirement" xmlns:ns5="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/educational" xmlns:ns6="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/annotation" xmlns:ns7="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/classification" xmlns:ns8="http://phaidra.univie.ac.at/XML/metadata/lom/V1.0/organization" xmlns:ns9="http://phaidra.univie.ac.at/XML/metadata/histkult/V1.0">
  <ns1:general>
    <ns1:identifier>o:869</ns1:identifier>
    <ns1:title language="sr">Značaj kliničkih i biohemijskih parametara za tok, prognozu i kvalitet života bolesnika sa sistemskim eritemskim lupusom : doktorska disertacija</ns1:title>
    <ns1:language>sr</ns1:language>
    <ns1:description language="en">Successful treatment and control of SLE requires precise assessment of disease
activity and quality of life, as well as determination of biologic markers in order to administer
proper therapy, to achieve disease remission, or to prevent or delay damage to the involved
organs and treatment complications.
This paper aimed to assess disease activity, degree of organ damage, and quality of life
of SLE patients, using appropriate questionnaires and establishing their correlation; to
determine the prevalence, specificity, and sensitivity of anti-nucleosome antibodies, anti-C1q
antibodies, and serum and urinary monocyte chemoattractant protein-1 (MCP-1), and to
identify their possible association with active forms of SLE and lupus nephritis.
The studied group comprised 85 SLE patients, while 30 healthy examinees comprised
the control group. In all examinees, in addition to standard clinical examination and
supplementary diagnostic procedures, the levels of anti-nucleosome antibodies, anti-C1q
antibodies, and serum and urinary MCP-1 were determined by way of the ELISA method.
Disease activity was also assessed using the SLEDAI, ECLAM, and LAI questionnaires and
by way of global physician assessment; organ damage was assessed using the SDI damage
index, quality of life was assessed using the SF-36 questionnaire, and fatigue severity was
measured using the FSS fatigue scale.
Based on the completed study, a conclusion may be drawn that disease activity did not
correlate with organ damage, quality of life, and fatigue severity. Anti-C1q antibodies and
simultaneous positivity of anti-nucleosome, anti-C1q and anti-dsDNA antibodies were
associated with lupus nephritis activity. Urinary MCP-1 demonstrated a highest association
with active lupus nephritis forms, being in high positive correlation with the degree of
proteinuria and in negative correlation with glomerular filtration rate.</ns1:description>
    <ns1:description language="sr">Biografija: list [152]Umnoženo za odbranu. Univerzitet u Nišu, Medicinski fakultet, 2013. Bibliografija: listovi 120-133. Sažetak ; Summary. </ns1:description>
    <ns2:identifiers>
      <ns2:identifier>1024663021</ns2:identifier>
    </ns2:identifiers>
    <ns2:identifiers>
      <ns2:resource>91552101</ns2:resource>
      <ns2:identifier>1309</ns2:identifier>
    </ns2:identifiers>
    <ns2:identifiers>
      <ns2:resource>91552100</ns2:resource>
      <ns2:identifier>1024663021</ns2:identifier>
    </ns2:identifiers>
  </ns1:general>
  <ns1:lifecycle>
    <ns1:upload_date>2014-10-14T18:42:46.053Z</ns1:upload_date>
    <ns1:status>45</ns1:status>
    <ns2:peer_reviewed>no</ns2:peer_reviewed>
    <ns1:contribute seq="0">
      <ns1:role>46</ns1:role>
      <ns1:ext_role>mentor</ns1:ext_role>
      <ns1:entity seq="0">
        <ns3:firstname> Valentina, 1965-</ns3:firstname>
        <ns3:lastname>Živković</ns3:lastname>
      </ns1:entity>
      <ns1:date>2013</ns1:date>
    </ns1:contribute>
    <ns1:contribute seq="1">
      <ns1:role>63</ns1:role>
      <ns1:ext_role>mentor</ns1:ext_role>
      <ns1:entity seq="0">
        <ns3:firstname> Aleksandra</ns3:firstname>
        <ns3:lastname>Stanković</ns3:lastname>
      </ns1:entity>
      <ns1:date>2013</ns1:date>
    </ns1:contribute>
    <ns1:contribute seq="2">
      <ns1:role>63</ns1:role>
      <ns1:ext_role>član komisije</ns1:ext_role>
      <ns1:entity seq="0">
        <ns3:firstname> Tatjana 1965-</ns3:firstname>
        <ns3:lastname>Cvetković</ns3:lastname>
      </ns1:entity>
      <ns1:date>2013</ns1:date>
    </ns1:contribute>
    <ns1:contribute seq="3">
      <ns1:role>63</ns1:role>
      <ns1:ext_role>član komisije</ns1:ext_role>
      <ns1:entity seq="0">
        <ns3:firstname> Nada 1955-</ns3:firstname>
        <ns3:lastname>Vujasinović-Stupar</ns3:lastname>
      </ns1:entity>
      <ns1:date>2013</ns1:date>
    </ns1:contribute>
  </ns1:lifecycle>
  <ns1:technical>
    <ns1:format>PDF/A (163 lista)</ns1:format>
    <ns1:size>5587544</ns1:size>
    <ns1:location>http://phaidrabg.bg.ac.rs/o:869</ns1:location>
  </ns1:technical>
  <ns1:rights>
    <ns1:cost>no</ns1:cost>
    <ns1:copyright>yes</ns1:copyright>
    <ns1:license>4</ns1:license>
  </ns1:rights>
  <ns1:annotation>
    <ns6:annotations>
      <ns6:date>2014-10-14T18:42:46.320Z</ns6:date>
    </ns6:annotations>
  </ns1:annotation>
  <ns1:classification>
    <ns1:purpose>70</ns1:purpose>
    <ns7:keyword language="sr" seq="1">Sistemski eritemski lupus, anti-C1q antitela, anti-nukleozomska antitela, monocitni hemoatraktant protein-1, lupusni nefritis, </ns7:keyword>
    <ns7:keyword language="sr" seq="1">anti-C1q antibodies, anti-nucleosome antibodies, monocyte chemoattractant protein-1, lupus nephritis, systemic lupus erythematosus</ns7:keyword>
    <ns7:keyword language="sr" seq="1">616</ns7:keyword>
  </ns1:classification>
  <ns1:organization>
    <ns8:hoschtyp>1738</ns8:hoschtyp>
    <ns8:orgassignment>
      <ns8:faculty>18A05</ns8:faculty>
      <ns8:department>18A0501</ns8:department>
    </ns8:orgassignment>
  </ns1:organization>
  <ns12:digitalbook>
    <ns12:releaseyear>2013</ns12:releaseyear>
  </ns12:digitalbook>
</ns0:uwmetadata>
